innoscripta Aktie
| 129,00EUR | 11,20EUR | 9,51% | 
WKN DE: A40QVM / ISIN: DE000A40QVM8
Personal
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 0 | 0 | 
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 
Bilanz (in Mio. EUR) - Aktiva
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Summe Umlaufvermögen | 17 | 29 | 35 | 58 | 
| Summe Anlagevermögen | 0 | 1 | 1 | 1 | 
| Summe Aktiva | 17 | 30 | 35 | 59 | 
Bilanz (in Mio. EUR) - Passiva
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Summe Fremdkapital | 7 | 17 | 17 | 24 | 
| Summe Eigenkapital | 11 | 13 | 18 | 35 | 
| Summe Passiva | 17 | 30 | 35 | 59 | 
Adresse
| Arnulfstrasse 60, 80335 Munich | |
| Telefon | +49 (89) 25555-3537 | 
| Internet | http://www.innoscripta.com | 
Management
| 
						Alexander Meyer
						 Chief Financial Officer  | 
				
| 
						Christoph Möller
						 Deputy Chairman-Supervisory Board  | 
				
| 
						Duygu Uysal
						 Member-Supervisory Board  | 
				
| 
						Erik Massmann
						 Member-Supervisory Board  | 
				
| 
						Kai Andrejewski
						 Member-Supervisory Board  | 
				
| 
						Michael Georg Hohenester
						 Chief Executive Officer  | 
				
| 
						Philipp von Ilberg
						 Chairman-Supervisory Board  | 
				
| 
						Sebastian Schwertlein
						 Chief Operating Officer  | 
				
| 
						Stefan Berndt-von Bülow
						 Member-Supervisory Board  |